Zevra Therapeutics(DE:1GDA)
€9.90-0.65 (-6.16%)
DE:1GDA
Zevra Therapeutics earnings date
€9.90
At close:-0.65 (-6.16%)
Zevra Therapeutics (1GDA) Q2 2024 Earnings Report
1 Followers
DE:1GDA Q2 2024 EPS Results
- Actual EPS
- -EUR 0.43
- Consensus EPS
- -EUR 0.41
- Beat/Miss
- Missed by -EUR 0.02
- One Year Ago EPS
- -EUR 0.14
DE:1GDA Q2 2024 Revenue Results
- Actual Revenue
- EUR 4.02M
- Expected Revenue
- EUR 3.95M
- Beat/Miss
- Beat by +EUR 75.93K
- YoY Revenue Growth
- -47.47%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/13/2024
- Time
- After Close
- Conference Call
- Tuesday, August 13, 2024
DE:1GDA Upcoming Earnings
Zevra Therapeutics's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1GDA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | 0.17- | 0.17 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | 0.140.24 | -0.01 | 2700.00% (+0.24) | |
| Aug 05, 2026 | 2026 (Q2) | 0.100.13 | 1.09 | -88.43% (-0.97) | |
| May 06, 2026 | 2026 (Q1) | 0.070.54 | -0.05 | 1100.00% (+0.60) | |
| Mar 09, 2026 | 2025 (Q4) | 0.050.17 | -0.61 | 128.36% (+0.78) | |
| Nov 05, 2025 | 2025 (Q3) | -0.03-0.01 | -0.62 | 98.55% (+0.61) | |
| Aug 12, 2025 | 2025 (Q2) | 2.051.09 | -0.43 | 352.08% (+1.53) | |
| May 13, 2025 | 2025 (Q1) | -0.16-0.05 | -0.36 | 85.00% (+0.31) | |
| Mar 11, 2025 | 2024 (Q4) | -0.36-0.61 | -0.46 | -31.37% (-0.14) | |
| Nov 12, 2024 | 2024 (Q3) | -0.37-0.62 | -0.36 | -72.50% (-0.26) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
